Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reissue Patent
2007-04-17
2007-04-17
Low, Christopher S. F. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
Reissue Patent
active
09742993
ABSTRACT:
The invention provides a composition for attenuating neovascularization and treating malignancies, including a pharmaceutically effective amount of a compound having a formula:wherein:R1is a member of the group consisting of hydrogen, halogen, nitro, benzo, lower alkyl, phenyl and lower alkoxy;R2is a member of the group consisting of hydroxy, acetoxy, and lower alkoxy, andR3is a member of the group consisting of hydrogen and lower alkenoxy carbonyl;as active ingredient therein, in combination with a pharmaceutically acceptable carrier.
REFERENCES:
patent: 4340596 (1982-07-01), Schein
Knighton, et al, “Regulation of Cutaneous Wound Healing by Growth Factors and the Microenvironment”, Investigative Radiology, vol. 26, No. 6, pp. 604-611, (1991).
Haukipuro et al, “Synthesis of Typr I Collagen in Healing Wounds in Humans”, Ann of Surg., vol. 213, No. 1 pp. 75-80, (1991).
Grant et al, “Increased Skin Tearing in Broilers and Reduced Collagen Synthesis in Skin In Vivo and In Vitro In Response to the Coccidiostat Halofuginone”, Poultry Science, 70:1559-1563 (1991).
Ashcroft, The Effects of Ageing on Cutaneous Wound Healing in Mammals, J. Anat., vol. 187, pp. 1-26, (1995).
Choi et al, “Halofuginine, A Specific Collagen Type I Inhibitor, Reduces Anastomic Intimal Hyperplasia” Arch. Surg., vol. 130, pp. 257-261 (1995).
Freidman, et al “Regulation in Collagen Gene expression in Keloids and Hypertrophic Scars”, J. Surg. Res., 55:214-222 (1993).
Rockwell, et al, “Keloids and Hypertrophic Scars: A Comprehensive Review”, Plastic and Recon. Surg., vol. 84, No. 5, pp. 827-836, (1989).
Dauo-Brown, D.D., “Keloids: A Review of the Literature”, Brit. J. Plastic Surg., 43:70-77, (1990).
Nagler, et al, “Inhibition of Collagen Synthesis, Smooth Muscle Cell Proliferation, and Injury-Induced Intimal Hyperplasia by Halofuginone”, Arter. Thromb. & Vasc. Biol., vol. 17, No. 1, pp. 1-9 (1997).
Tulandi, T. “Prevention of Postoperative Intra-Abdominal Adhesions”, Curr. Opin in Obst. & Gyn., 2:87-290,(1990).
Menzies, D., “Postoperative Adhesions: Their.Treament and relevance in Clinical Practice”, Ann. Roy. Col. Surg., vol. 75, 147-153, (1993).
Drollette, et al, “Pathophysiology of Pelvic Adhesions”, J. Reprod. Med., vol. 37, No. 2, pp. 107-122 (1992).
Monk et al, “Adhesion after Extensive Gynecologic Surgery: Clinical Significance, Etiology and Prevention”, Am. J. Obstet.Gynecol, vol. 170, No. 5, Part 1, pp. 1396-1403 (1994).
Glinski et al, “Alterations of T-cell Extracellular Matrix Proteins interactions in Psiorasis”, (1993).
Holz et al, “Inhibition of Peritoneal Adhesion Reformation After Lysis with Thirty-Two Percent Dextran 70”, Fertility and Sterility, vol. 34, No. 4, pp. 394-395 (1980).
Menzies et al, “Intra-Abdominal Adhesions and Thei Prevention by Topical Tissue Plasminogen Activator”, J. Roy. Soc. Med., vol. 82 pp. 534-535 (1989).
Raftery, A.T., “Effect of Peritoneal Trauma on Peritoneal Fibrinolytic Activity and Intraperitoneal Adhesion Formation”, Eur. Surg. Res., 13:397-401 (1981).
Rivkind et al, “Urokinase Does Not Prevent Abdominal Adhesion Formation in Rats”, Eur. Surg. Res., 17:254-258 (1985).
Weibel et al, “Peritoneal Adhesions and their Relation to Abdominal Surgery”, Am. J. Of Surg., vol. 126, pp. 345-353 (1973.
Gilmore et al “Prevention of Peritoneal Adhesions by a New Providone-Iodine/PVP Solution”, J. Of Surg. Res., J. Of Surg. Res., vol. 25, pp. 477-481 (1978).
Rivkind et al, Cianidanol ([+]-Cianidanol-3) Prevents the Development of Abdominal Adhesions in Rats), Arch. Surg., vol. 118, pp. 1431-1433 (1983).
Menzies et al, “The Role Plasminogen Acrivator in Adhesion Prevention”, Surg., Gynecol. & Obstet., vol. 172, pp. 361-366 (1991).
Brooks et al “Integrin .alpha..sub.v.beta..sub.3 Antagonists Promote Tumor Regression by Inducing Apoptosis of Angeogenic Blood Vessels”, Cell, vol. 79, pp. 1157-1164 (1994).
Folkman et al, “Angiogenesis”, J. Of Biological Che, vol. 267 No. 16, pp. 109031-109 (1992).
Folkman et al, “Angiogenic Factors”, Science, vol. 235, pp. 442-447 (1987).
Folkman, J., “Toward an Understanding of Angiogenesis: Search & Discovery”, Persp. In Biol. & Med.,pp. 11-37 (1985).
Salo et al, “Effect of Phenytoin and Nifedipine on Collagen Gene expression in Humah Gingival Fibroblasts”, (1990.
Nickoloff et al, “Abberant Production of Interluekin-8 and Thrombospondin-1 by Psoriatic Keratinocytes Mediates Angiogenesis”, Am. J. Path. vol. 144, No. 4, pp. 820-828 (1994).
Mahadevan et al, “The Effects of Ovarian Adhesive Disease Upon Follicular Development in Cycles of Controlled Stimulation for In Vitro Fertilization”, Fertility & Sterility, vol. 44, No. 4, pp. 489-492 (1985).
Takahashi et al, “Cellular Markers That Distingui the Phases of Hemangioma during Infancy and Childhoold”, J. Clin. Invest., vol. 93, pp. 2357-2364 (1994).
Weidner et al, “Tumor Angiogenisis Correlates with Metastasis in Invasive Prostate Carcinoma”, Am. J. Path., vol. 143, No. 2, pp. 401-409 (1993).
Folkman, J., “What is the Evidence That Tumors are Angiogenesis dependent?”, J. Nat'l. Cancer Inst., vol. 82, No. 1, pp. 4-6, (1989).
Peacock et al, “Angiogenesis Inhibition Suppresses Collagen Arthritis”, J. Exp. Med., vol. 175, pp. 1135-1138 (1992).
Miller et al “Vascular Endothelial Growth factor/Vascular Permeability factor is tempoarilyand Spatially Correlated with Ocular Angiogenesis in a Primate Model”, Am. J. Path., vol. 145, No. 3, pp. 574-584 (1994).
Folkman, J., “Angiogenesis in Cancer, Vascular, Rheumatoid and Other Disease”, Nature Medicine, vol. 1, No. 1, pp. 27-31 (1995).
Bischoff, J. “Approaches to Studying Cell Adhesion Molecules in Angiogenesis”, Trends in Cell Biol., vol. 5, pp. 69-74 (1995).
Sawhney et al “Optimization of Photopolymerized Bioerodable Hydrogel Properties for Adhesion Prevention”, J. Biomed. Mat. Res., vol. 28, pp. 831-838 (1994).
Jackson et al, “Type 1 Collagen Fibrils Promote Rapid Vascular Tube Formation Upon Contact with the Apical Side of Cultured Endothelium”, Exp. Cell Res., 192:319-323 (1991).
Iruela-Arispe et al, “Differential Expression of Extracellular Proteins is Correlated with Angiogenesis In Vitro”, Lab. Invest., vol. 64, No. 2, pp. 174-186 (1991).
Ingber et al, “Synthetic Analogues of Fumagillin that Inhibit Angiogenesis and Suppress Tumor Growth”, Nature, vol. 348, pp. 555-557 (1990).
Castle et al, “Antisense-Mediated Reduction in Thrombospondin Reverses the Mlignant Phenotype of a Human Squamous Carcinoma”, J. Cli. Invest., vol. 87, pp. 1883-1888 (1991).
Hill-West et al, “Efficacy of a Resorable Hydrogel Barrier, Oxidized Regenerated Cellulose, and Hyaluronic Acid in the Prevention of Ovarian Adhesions in a Rabbit Model”, Fertility & Sterility, vol. 62. No. 3, pp. 630-634 (1994).
Vick, “Statistics of Acute Intestinal Obstruction” Brit. Med. J., pp. 546-548 (1932).
Mian Hua-Quan
Nagler Arnon
Pines Mark
Vlodavsky Israel
Agricultural Research Organization Ministry of Agriculture
Hadasit Medical Research Services and Development Company Ltd.
Lewis Amy
Low Christopher S. F.
Sullivan & Worcester LLP
LandOfFree
Quinazolinone containing pharmaceutical compositions for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinazolinone containing pharmaceutical compositions for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinazolinone containing pharmaceutical compositions for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3780681